Aller au contenu principal
Profil bibliographique

Geneviève Bouchard‐Fortier

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

122Publications signalées
1253Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Ovarian cancer diagnosis and treatmentEndometrial and Cervical Cancer TreatmentsIntraperitoneal and Appendiceal MalignanciesCervical Cancer and HPV ResearchGestational Trophoblastic Disease Studies

Les publications récentes

Accès ouvert 2026 article OpenAlex

Patient-Reported Symptom Burden and Temporal Trends During the First 18 Months After Gynecologic Cancer Diagnosis: A Population-Based Study

Lauren Philp, Geneviève Bouchard‐Fortier, Lilian Tran Gien, Sarah Elizabeth Ferguson et autres

Objectives: Our objectives were to evaluate symptom prevalence, severity, and temporal trends ≤ 18 months from gynecologic cancer (Gyn-Ca) diagnosis using the ESAS-r questionnaire and to identify predictors of elevated symptom burden. Methods: We performed a retrospective population-based study of newly diagnosed …

ca (code pays fourni par la source)

0 citations Cancers
Accès ouvert 2026 article OpenAlex

Impact of Marginalization Dimensions on Survival Disparities in Epithelial Ovarian Cancer: An Ontario Population-Based Study

Justin Wei-Jia Lim, Lilian Tran Gien, Zharmaine Ante, Ning Liu et autres

Objectives: We aimed to examine associations between social marginalization, defined by the Ontario Marginalization Index (“ON-Marg”), and overall survival (OS) in epithelial ovarian cancer (EOC). Methods: This was a population-based retrospective cohort study using linked administrative data in Ontario, Canada, including adults …

ca (code pays fourni par la source)

0 citations Cancers
Accès ouvert 2026 article OpenAlex

Refractory ultra–high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti–PD-L1 therapy

Laura Venegas, Brooke Grant, Ana C. Veneziani, Stephanie Lheureux et autres

Background: Choriocarcinoma is a highly aggressive gestational trophoblastic neoplasm. Patients with ultra-high-risk disease (FIGO score ≥ 13) and brain metastases face cure rates of only 50–80% and require intensive multimodal therapy. Case: We present the case of a 37-year-old woman with stage …

ca (code pays fourni par la source)

0 citations Gynecologic Oncology Reports
2026 conference-abstract OpenAlex

Enhancing supportive care in malignant bowel obstruction: A QI project using virtual dietitian-led low-fiber diet education.

Bojan Macanovic, Vikas Garg, Nazlin Jivraj, Karmen HT More et autres

12068 Background: Malignant bowel obstruction (MBO) is a frequent, debilitating complication in patients with gynecologic malignancies associated with poor prognosis. Low-fibre diet (LFD) is a core component of conservative management; however, adherence is challenging and may be improved with coaching. To address …

ca (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High‐Grade Serous Ovarian Cancer: A Retrospective Cohort Study

Anouk Benseler, Adina Tanen, Taymaa May, Lisa M. Avery et autres

BACKGROUND AND OBJECTIVE: Stage IVB high-grade serous ovarian cancer (HGSOC) carries a poor prognosis. We aimed to: (1) describe the characteristics and survival of patients treated with primary cytoreductive surgery (PCS), interval cytoreductive surgery (ICS) or chemotherapy alone, (2) investigate the correlation …

ca, us (code pays fourni par la source)

0 citations Journal of Surgical Oncology
Accès ouvert 2025 article OpenAlex

Description of first recurrence in advanced stage high grade serous ovarian cancer receiving intraperitoneal versus intravenous systemic treatment

Auni Lindgren, Anouk Benseler, Liat Ben-David Hogen, Taymaa May et autres

OBJECTIVES: To investigate the association of adjuvant intraperitoneal (IP) and intravenous (IV) chemotherapy with location and timing of recurrence in patients with advanced high grade serous ovarian cancer (HGSOC). METHODS: This retrospective cohort study includes patients with stage III or IV HGSOC …

fi, ca, us (code pays fourni par la source)

0 citations Gynecologic Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.